Biotech Co. Says BP Unit Conducted Negligent Enzyme Work

Law360, New York (August 31, 2012, 4:38 PM EDT) -- Biotech company Verenium Corp. accused a BP PLC unit in New York state court Thursday of failing to properly perform certain enzyme production services under a $1.8 million agreement between the companies, threatening the viability of a new Verenium product.

BP Biofuel North America LLC had negligently failed to maintain its equipment or control its staff to a “commercially reasonable” standard under the bio-fermentation service contract, causing the failure of a number of enzyme production runs, including a critical test necessary to commercialize an upcoming Verenium...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.